For: | Jehangir A, Parkman HP. Chronic opioids in gastroparesis: Relationship with gastrointestinal symptoms, healthcare utilization and employment. World J Gastroenterol 2017; 23(40): 7310-7320 [PMID: 29142478 DOI: 10.3748/wjg.v23.i40.7310] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i40/7310.htm |
Number | Citing Articles |
1 |
Richard W. McCallum, Ashish Malhotra, Marco A. Bustamante Bernal, Luis O. Chavez. Geriatric Gastroenterology. 2019; : 1 doi: 10.1007/978-3-319-90761-1_41-1
|
2 |
Klaus Bielefeldt. Time Trends in Healthcare Utilization Due to Self-Reported Functional Diseases of the Stomach. Digestive Diseases and Sciences 2020; 65(10): 2824 doi: 10.1007/s10620-020-06154-0
|
3 |
Saam Dilmaghani, Ting Zheng, Michael Camilleri. Epidemiology and Healthcare Utilization in Patients With Gastroparesis: A Systematic Review. Clinical Gastroenterology and Hepatology 2023; 21(9): 2239 doi: 10.1016/j.cgh.2022.07.011
|
4 |
Ting Zheng, Michael Camilleri. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. 2023; : 99 doi: 10.1016/B978-0-443-13911-6.00033-5
|
5 |
Adil E Bharucha, Yogish C Kudva, David O Prichard. Diabetic Gastroparesis. Endocrine Reviews 2019; 40(5): 1318 doi: 10.1210/er.2018-00161
|
6 |
Journey L. Wise, Maria I. Vazquez-Roque, Caleb J. McKinney, Michael A. Zickella, Michael D. Crowell, Brian E. Lacy. Gastric Emptying Scans: Poor Adherence to National Guidelines. Digestive Diseases and Sciences 2021; 66(9): 2897 doi: 10.1007/s10620-020-06314-2
|
7 |
Amber Shada, Alex Nielsen, Sarah Marowski, Melissa Helm, Luke M. Funk, Andrew Kastenmeier, Anne Lidor, Jon C. Gould. Wisconsin's Enterra Therapy Experience: A multi-institutional review of gastric electrical stimulation for medically refractory gastroparesis. Surgery 2018; 164(4): 760 doi: 10.1016/j.surg.2018.04.043
|
8 |
Allen A. Lee, Krishna Rao, Henry P. Parkman, Richard W. McCallum, Irene Sarosiek, Linda A. Nguyen, John M. Wo, Michael I. Schulman, Baharak Moshiree, Satish Rao, Braden Kuo, William L. Hasler. Baseline Predictors of Longitudinal Changes in Symptom Severity and Quality of Life in Patients With Suspected Gastroparesis. Clinical Gastroenterology and Hepatology 2022; 20(3): e407 doi: 10.1016/j.cgh.2020.09.032
|
9 |
Jan Tack, K. Van den Houte, Florencia Carbone. Gastroduodenal motility disorders. Current Opinion in Gastroenterology 2018; 34(6): 428 doi: 10.1097/MOG.0000000000000473
|
10 |
J D Gomez Cifuentes, P N Thota, R Lopez. Lower prevalence of gastroesophageal reflux disease in patients with noncardiac chest pain on opiates: a cross-sectional study. Diseases of the Esophagus 2018; 31(11) doi: 10.1093/dote/doy053
|
11 |
Michael Camilleri, Victor Chedid, Alexander C. Ford, Ken Haruma, Michael Horowitz, Karen L. Jones, Phillip A. Low, Seon-Young Park, Henry P. Parkman, Vincenzo Stanghellini. Gastroparesis. Nature Reviews Disease Primers 2018; 4(1) doi: 10.1038/s41572-018-0038-z
|
12 |
Asad Jehangir, Alexis Collier, Mohammed Shakhatreh, Zubair Malik, Henry P. Parkman. Caregiver Burden in Gastroparesis and GERD: Correlation with Disease Severity, Healthcare Utilization and Work Productivity. Digestive Diseases and Sciences 2019; 64(12): 3451 doi: 10.1007/s10620-019-05723-2
|
13 |
Namisha Thapa, Matthew Kappus, Ryan Hurt, Sarah Diamond. Implications of the Opioid Epidemic for the Clinical Gastroenterology Practice. Current Gastroenterology Reports 2019; 21(9) doi: 10.1007/s11894-019-0712-7
|
14 |
Yan Dong, Shiying Li, Jieyun Yin, Jiande D. Z. Chen. Ameliorating effects of optimized gastric electrical stimulation and mechanisms involving nerve growth factor and opioids in a rodent model of gastric hypersensitivity. Neurogastroenterology & Motility 2019; 31(5) doi: 10.1111/nmo.13551
|
15 |
Raphael Figuiredo Dias, Mirella Monique Lana Diniz, Bruno Campos Santos, Vandack Alencar Nobre. Gastrointestinal dysmotility in a patient with advanced lung cancer: paraneoplastic or drug-induced?. BMJ Case Reports 2021; 14(1): e237835 doi: 10.1136/bcr-2020-237835
|
16 |
Morgan A. Sendzischew Shane, Baharak Moshiree. Esophageal and Gastric Motility Disorders in the Elderly. Clinics in Geriatric Medicine 2021; 37(1): 1 doi: 10.1016/j.cger.2020.08.002
|
17 |
Dhyanesh Patel, James Callaway, Michael Vaezi. Opioid-Induced Foregut Dysfunction. American Journal of Gastroenterology 2019; 114(11): 1716 doi: 10.14309/ajg.0000000000000354
|
18 |
Madhusudan Grover, Gianrico Farrugia, Vincenzo Stanghellini. Gastroparesis: a turning point in understanding and treatment. Gut 2019; 68(12): 2238 doi: 10.1136/gutjnl-2019-318712
|
19 |
Paolo Usai-Satta, Massimo Bellini, Olivia Morelli, Francesca Geri, Mariantonia Lai, Gabrio Bassotti. Gastroparesis: New insights into an old disease. World Journal of Gastroenterology 2020; 26(19): 2333-2348 doi: 10.3748/wjg.v26.i19.2333
|
20 |
Heithem Soliman, Guillaume Gourcerol. Targeting the pylorus in gastroparesis: From physiology to endoscopic pyloromyotomy. Neurogastroenterology & Motility 2023; 35(2) doi: 10.1111/nmo.14529
|
21 |
Sameer Awsare, Carol Havens, Joseph Lippi. Facing the Opioid Crisis: Practical, Effective Actions We Can Take. Gastroenterology 2019; 156(6): 1538 doi: 10.1053/j.gastro.2018.12.035
|
22 |
Jolien Schol, Lucas Wauters, Ram Dickman, Vasile Drug, Agata Mulak, Jordi Serra, Paul Enck, Jan Tack. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. Neurogastroenterology & Motility 2021; 33(8) doi: 10.1111/nmo.14237
|
23 |
Charlène Gadais, Justyna Piekielna-Ciesielska, Jolien De Neve, Charlotte Martin, Anna Janecka, Steven Ballet. Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics. Molecules 2021; 26(17): 5406 doi: 10.3390/molecules26175406
|
24 |
Olubunmi Oladunjoye, Asad Jehangir, Adeolu Oladunjoye, Anam Qureshi, Zubair Malik, Henry P. Parkman. Features and Assessments of Pain, Anaesthesia, and Analgesia. 2022; : 173 doi: 10.1016/B978-0-12-818988-7.00007-8
|
25 |
Asad Jehangir, Henry P. Parkman. Cannabinoid Use in Patients With Gastroparesis and Related Disorders: Prevalence and Benefit. American Journal of Gastroenterology 2019; 114(6): 945 doi: 10.14309/ajg.0000000000000181
|
26 |
Jolien Schol, Lucas Wauters, Ram Dickman, Vasile Drug, Agata Mulak, Jordi Serra, Paul Enck, Jan Tack. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. United European Gastroenterology Journal 2021; 9(3): 287 doi: 10.1002/ueg2.12060
|
27 |
Richard W. McCallum, Ashish Malhotra, Marco A. Bustamante Bernal, Luis O. Chavez. Geriatric Gastroenterology. 2021; : 1145 doi: 10.1007/978-3-030-30192-7_41
|
28 |
Michael Camilleri, Kenton M. Sanders. Opiates, the Pylorus, and Gastroparesis. Gastroenterology 2020; 159(2): 414 doi: 10.1053/j.gastro.2020.04.072
|
29 |
Christopher M. Navas, Erica D. Wadas, Natalia H. Zbib, Michael D. Crowell, Brian E. Lacy. Gastroparesis and Severity of Delayed Gastric Emptying: Comparison of Patient Characteristics, Treatments and Medication Adverse Events. Digestive Diseases and Sciences 2021; 66(2): 526 doi: 10.1007/s10620-020-06258-7
|
30 |
Asad Jehangir, Rany T. Abdallah, Henry P. Parkman. Characterizing Abdominal Pain in Patients With Gastroparesis Into Neuropathic and Nociceptive Components. Journal of Clinical Gastroenterology 2019; 53(6): 427 doi: 10.1097/MCG.0000000000001059
|
31 |
Abdullah S. Shaikh, Mhd Yassin Al Mouslmani, Aun Raza Shah, Zarak Hassan Khan, Mohamed Tausif Siddiqui, Hamzeh Saraireh, Saurabh Chandan, Shifa Umar, Sumant Arora, Madhav Desai, Praveen Guturu, Mohammad Bilal. Preexisting opioid use disorder is associated with poor outcomes in hospitalized acute pancreatitis patients. European Journal of Gastroenterology & Hepatology 2021; 33(11): 1348 doi: 10.1097/MEG.0000000000002265
|
32 |
Paolo Usai-Satta, Massimo Bellini, Olivia Morelli, Francesca Geri, Mariantonia Lai, Gabrio Bassotti. Gastroparesis: New insights into an old disease. World Journal of Gastroenterology 2020; 26(19): 2332 doi: 10.3748/wjg.v26.i19.2332
|
33 |
David Yi Yang, Michael Camilleri. The goals for successful development of treatment in gastroparesis. Neurogastroenterology & Motility 2024; 36(10) doi: 10.1111/nmo.14849
|
34 |
Abraham Ifrah, John Ebeid, Henry P. Parkman. Abdominal Pain and Chronic Opiate Use in Patients with Gastroparesis. Gastrointestinal Disorders 2024; 6(3): 765 doi: 10.3390/gidisord6030052
|
35 |
Zorisadday Gonzalez, Richard W. McCallum. Gastroparesis. 2021; : 265 doi: 10.1016/B978-0-12-818586-5.00020-X
|
36 |
Charlotte Desprez, Jérémie Jacques, Thomas Clavier, Timothée Wallenhorst, Anne Marie Leroi, Guillaume Gourcerol. Impact of anesthetics on pyloric characteristics measured using the EndoFLIP® system in patients with gastroparesis. Neurogastroenterology & Motility 2023; 35(10) doi: 10.1111/nmo.14651
|
37 |
Benson T Massey. GORD and GLP-1 receptor agonists: an emerging concern for gastroenterologists. Gut 2024; 73(2): 211 doi: 10.1136/gutjnl-2023-331027
|
38 |
Asad Jehangir, Henry P. Parkman. Rome IV Diagnostic Questionnaire Complements Patient Assessment of Gastrointestinal Symptoms for Patients with Gastroparesis Symptoms. Digestive Diseases and Sciences 2018; 63(9): 2231 doi: 10.1007/s10620-018-5125-1
|
39 |
Mohammad Bilal, Ahmed Chatila, Mohamed Tausif Siddiqui, Muhannad Al-Hanayneh, Aun Raza Shah, Madhav Desai, Vaibhav Wadhwa, Sreeram Parupudi, Brenna W. Casey, Kumar Krishnan, Yasmin G. Hernandez-Barco. Rising Prevalence of Opioid Use Disorder and Predictors for Opioid Use Disorder Among Hospitalized Patients With Chronic Pancreatitis. Pancreas 2019; 48(10): 1386 doi: 10.1097/MPA.0000000000001430
|